Are hormones the final frontier for women with ADHD? | 6

Summary

Climbing the Walls: Are Hormones the Final Frontier for Women with ADHD? | Episode 6

Released on May 7, 2025

Introduction

In the sixth episode of Climbing the Walls, hosted by Danielle Elliott from Understood.org, the discussion delves into the intricate relationship between hormones and Attention Deficit Hyperactivity Disorder (ADHD) in women. Titled "Are hormones the final frontier for women with ADHD?", this episode investigates why ADHD diagnoses in women surged post-pandemic and explores the evolving understanding of how hormonal fluctuations impact ADHD symptoms.

The Untold Story: ADHD and Women's Hormonal Health

For decades, medical research predominantly focused on men, assuming findings would be universally applicable. This oversight left a significant gap in understanding how hormonal changes affect women with ADHD. Danielle Elliott contextualizes this historical neglect by highlighting the late inclusion of women in clinical research, a shift initiated by the NIH in 1986 and furthered by the 1993 federal law mandating women's participation in studies.

Rising ADHD Diagnoses Among Women

The podcast underscores a dramatic increase in ADHD diagnoses among women since the pandemic. This rise has sparked a multitude of questions regarding the role of hormones in exacerbating ADHD symptoms. Women have taken to platforms like Reddit to share their experiences, revealing patterns of heightened cognitive difficulties, irritability, and sensitivity aligned with menstrual cycles, postpartum periods, perimenopause, and menopause.

Danielle Elliott reads a Reddit post:

"So at least I know why these issues are happening. And that's kind of a relief. I'm not broken. I'm not not trying hard enough. I'm not a mutant. Why doctors didn't tell me this before now? No effing clue."
[00:01]

Breakthrough Research: Ashley Eng’s Pioneering Study

A cornerstone of the episode is the groundbreaking research led by Ashley Eng, featured at [06:12]. Eng, working under Dr. Michelle Martell at the University of Kentucky's Risk Lab, investigated how hormonal fluctuations during puberty affect ADHD symptoms in young women. Her study, published in Hormones and Behavior in February 2024, confirmed that ADHD symptoms vary across menstrual cycles, correlating with levels of estrogen and progesterone.

Key Findings from Ashley Eng:

• Inattention and Progesterone: A positive association was found, indicating increased inattention during phases of elevated progesterone.
• Hyperactivity and Estradiol: A negative association suggested reduced hyperactivity when estradiol levels are higher.

Ashley Eng explains:

"Broadly, we found that ADHD symptoms are changing across the menstrual cycle. We also saw some connections with different hormones."
[07:54]

These findings validate what many women have been experiencing and pave the way for potential personalized treatments, such as adjusting ADHD medication dosages in sync with hormonal cycles or using hormone-based therapies to stabilize ADHD symptoms.

Duke University’s Inclusive Research Approach

The episode highlights Duke University's innovative approach through the Center for Girls and Women with ADHD. Co-directed by Dr. Julia Schechter, the center prioritizes understanding women's perspectives by conducting "listening and learning sessions" with diverse groups, including postmenopausal women, teen girls, parents, and healthcare providers.

Dr. Julia Schechter shares:

"What we want more of is to better understand the role of hormones on ADHD symptoms and how it impacts ADHD across the lifespan."
[16:40]

This grassroots approach resulted in identifying key research priorities directly from the affected population, emphasizing the critical need for studies tailored to women's unique hormonal landscapes.

Personal Narratives: The Quest for Answers

Emily Mitchell's poignant story illustrates the real-world implications of the research gaps. Diagnosed with ADHD in her youth, Emily faced cognitive challenges exacerbated by hormone-blocking treatments for breast cancer. Her experience underscores the urgent need for evidence-based guidelines on managing ADHD alongside hormonal therapies.

Emily Mitchell recounts:

"So if you're losing estrogen, what else have you got? You know, you give up that. So what's going to happen? Will I lose my mind?"
[22:05]

Her subsequent adjustment in ADHD medication following estrogen blocker treatment demonstrates the delicate balance required in managing ADHD amidst hormonal changes.

Expert Opinions and Future Directions

The episode features insights from Dr. Russell Barkley, a prominent ADHD expert, who lauds Ashley Eng's study for addressing the long-overlooked hormonal factors influencing ADHD in women. He notes the shrinking gender gap in ADHD diagnoses as women increasingly come forward with their experiences.

Dr. Russell Barkley states:

"It's what women have been saying all along. Hormones."
[13:46]

Looking forward, the episode discusses the potential of artificial intelligence (AI) in accelerating research and developing personalized ADHD treatments. Innovations like AI-driven diagnostic tools and treatment effectiveness studies offer hope for more nuanced and timely interventions.

Challenges and Societal Implications

Despite promising research, significant challenges remain. The slow pace of scientific discovery, coupled with limited funding, hinders the development of tailored treatments. Additionally, societal expectations and the reliance on technology exacerbate ADHD management difficulties, suggesting that solutions must extend beyond individual treatments to encompass broader societal changes.

Conclusion: A Call to Prioritize Women's Health in ADHD

Danielle Elliott concludes by asserting that the surge in ADHD diagnoses among women is not merely a product of increased awareness but a reflection of longstanding neglect in prioritizing women's health. The episode advocates for continued research focused on hormonal impacts, personalized treatment strategies, and societal reforms to support women with ADHD effectively.

Final Reflection:

"The Pandemic and TikTok. Ned Hallowell told me there's environmentally induced ADHD and that modern life is making ADHD symptoms worse... But the need for societal solutions doesn't replace the need for individual treatment. And it's time for that individual treatment to consider the experiences of women."
[23:46]

Credits

Climbing the Walls is brought to you by Understood.org, a nonprofit organization dedicated to empowering individuals with learning and thinking differences like ADHD and dyslexia. The episode was produced by Danielle Elliott, with contributions from Neil Drumming, Cody Nelson, Brianna Berry, Ash Beecher, Diana White, Mary Mathis, Karen Watanabe, Kwame Brandt Pierce, Blue Dot Sessions, and Justin D. Wright.

---

This comprehensive exploration in Climbing the Walls Episode 6 underscores the critical intersection of hormones and ADHD in women, advocating for a more inclusive and scientifically grounded approach to understanding and treating ADHD across different life stages.

Transcript

[Danielle Elliott]

My questions about ADHD and perimenopause fit into a bigger category, ADHD and hormones. And I'm not even slightly the only person asking about them. Women have posted all sorts of stories and questions about ADHD and hormones on Reddit. Allow me to read you one of those posts. Hey all, I just got back from a session with my psychiatrist and she shared with me something that's kind of blown my mind. Apparently that's in all caps. Girl hormones throw all sorts of wrenches into ADHD and ADHD medication. After that conversation with her psychiatrist, the woman started tracking her symptoms alongside her menstrual cycles. She noticed my life would be together for two weeks at a time and then go off the rails for about two weeks. It's like clockwork. The post is from four years ago. Back then it was filed under the hashtag tipsandtechniques. Today, there's an entire category on Reddit called ADHD and Hormone Related Issues. Women write about having increased cognitive difficulties, irritability, depression, rejection, sensitivity and other symptoms, usually during the second half of their menstrual cycles, during postpartum perimenopause and menopause. One woman said her ADHD eased when she became pregnant and then became unmanageable when she stopped breastfeeding. Another said she thought she had her ADHD handled until she hit perimenopause. She wrote, basically, it gets worse ladies. It's turbo adhd. In yet another post, a woman said she is fairly certain she has adhd, but her doctor can't diagnose her. Her symptoms came on during menopause, and According to the DSM, symptoms must start by the time a person turns 12. Her doctor is following that guideline. Reading this brought me back to my earlier question, is it possible to develop ADHD later in life? The women writing these posts are frustrated. The author of the first one captured the feeling well, she wrote, so at least I know why these issues are happening. And that's kind of a relief. I'm not broken. I'm not not trying hard enough. I'm not a mutant. Why doctors didn't tell me this before now? No effing clue. The questions and frustrations are not exactly new, Sari Solden told me. Women have been asking them for decades. But the rise in diagnosis means many more women are asking about hormones and adhd. Most of them want to know how to adjust treatment to account for these hormonal swings. Doctors and scientists don't have solid answers, at least not yet. On this final episode, I'm going to let you hear from a few researchers. We're going to talk a lot about hormones and why we don't yet understand scientifically how those hormones affect women with adhd, or whether it's possible to develop ADHD after the age of 12. We're going to hear what treatment might look like in the future. If. And that's a big if. If scientists and the agencies that fund scientific research choose to prioritize the needs of adult women with adhd. This is Climbing the Walls, a podcast where I try to figure out why so many women are being diagnosed with adhd. I'm Danielle Elliot. Let's go back in time just a little bit. For most of medical history, clinical research operated under the false assumption that if you study men, the findings will pertain to women. In 1986, the NIH issued a new policy encouraging scientists to include women in research studies. Things started to change in 1991 when a woman named Bernadine Healy became the first female NIH director. Two weeks into her tenure, Dr. Healy launched the Women's Health Initiative. Over the next 15 years, the initiative enrolled more than 150,000 postmenopausal women in clinical trials. The initiative is the reason we know about long term risks associated with hormone replacement therapies, especially when used by postmenopausal women. Still, the NIH policy recommendation didn't spread far and wide. Women with all our pesky hormones were just too difficult to study. Widespread change only started in 1993 when Congress passed a federal law requiring that women be included in clinical research. 1993. Thirty years later, I struggled to find researchers who are focusing on ADHD and hormones. I found studies showing that estrogen helps distribute important neurotransmitters like dopamine and serotonin throughout the brain, so that they can help with things like cognition and mood. When estrogen decreases and progesterone rises, it impacts brain function. The studies on estrogen and progesterone are helpful, but none of these studies are specifically about ADHD brains. And if we have any hope of developing better treatments for adhd, we need to know how this science specifically applies to ADHD brains, which, by the way, already have a hard time circulating these neurotransmitters, even on a good day. So how do these hormonal fluctuations impact ADHD brains? I looked for experts in this. There are several ADHD coaches and clinicians who specialize in supporting women during different life stages, but scientists who who study ADHD at these stages. I struggled to find any I Wondered if I just wasn't looking hard enough. Then in February 2024, a new study led me to potential answers.

[Ashley Eng]

So I had started off as kind of almost this in home aid, working with a young girl who was at the very beginning of puberty. And she was experiencing a lot of symptoms of ADHD as well as anxiety, depression and behavioral problems.

[Danielle Elliott]

This is Ashley Eng, the lead researcher on the February 2024 paper.

[Ashley Eng]

And as I was working with her over a couple years, I noticed that as she was going through puberty, everything just kind of got worse. Despite having a psychiatrist, me in the home helping her get off to school, the parents being very involved, things just seemed to keep getting worse. Despite all of the care that she.

[Danielle Elliott]

Was receiving, Ashley learned that this was not a unique situation. It seemed to occur with other kids around the same age.

[Ashley Eng]

And so with that, I really wanted to study when I was looking at PhD programs was what is going on during this time period around puberty that just seems to be making everything worse.

[Danielle Elliott]

Ashley chose the Risk lab at the University of Kentucky under the guidance of Dr. Michelle Martell. Dr. Martell was in the midst of an NIH funded study examining ADHD symptoms across the menstrual cycles of young women with adhd.

[Ashley Eng]

And I, during my interview, had proposed, have you thought about looking this in adolescents? So it was the perfect combination of I'd be able to help her with her research and she'd be able to help me learn how to do this research and learn how to look at this in adolescence.

[Danielle Elliott]

Ashley's research ultimately confirmed what women have been reporting for decades.

[Ashley Eng]

Broadly, we found that ADHD symptoms are changing across the menstrual cycle. We also saw some connections with different hormones.

[Danielle Elliott]

Several other factors impacted symptoms, including perceived stress, but the role of hormones was undeniable. Now, if you're thinking, yes, we know that hormones change symptoms, why do we need a scientist to confirm what thousands of women have already experienced? I get it. But that's how science and medical treatments work. To develop treatments that help with hormones and adhd, we need to understand the underlying science. For decades, it wasn't studied. Scientists focused on kids and teens with adhd, primarily boys with adhd. Technically, Ashley focused on adolescence. But because she studied hormones, her results can tell us about ADHD at different life stages. Her results show that analyses indicated inattention was positively associated with progesterone. Hyperactivity was negatively associated with estradiol, which is a type of estrogen. She determined that in the two points in the menstrual cycle when estrogen decreases, that's where ADHD symptoms are worse. These results line up with those of other studies at the risk lab, including the long term study that Ashley's mentor, Dr. Martell is working on.

[Ashley Eng]

We are seeing that for these young adult females, we're seeing very similar changes of hormones impacting ADHD symptoms. We're also thinking that there's other reproductive life events like pregnancy perimenopause that might also be experiencing these changes around ADHD symptoms.

[Danielle Elliott]

This aligns with what women and clinicians have long reported. But as far as scientific research, it's groundbreaking. Ashley told me the overall goal of her research is threefold. First, to understand hormones and ADHD next to personalized treatments. She said that in the future this could mean psychiatrists or doctors titrate ADHD medications throughout a woman's menstrual cycle so that on days when symptoms are worse, they take a higher dose of medication. Another possibility is prescribing hormone based medication like birth control to treat adhd. She emphasized that this is theoretical and these approaches have not yet been studied or tested. If treatments are developed, they won't be a one size fits all solution.

[Ashley Eng]

Now there's many different kinds of birth control where some stabilize hormone levels, others continue to have changes in hormone levels. There's different hormones involved in each one. So it's a very complicated process. But the thought is if that we're able to stabilize these shifts in hormones, we might be able to stabilize those ADHD symptoms.

[Danielle Elliott]

We'll also need research into different types of birth control. She mentioned a recent study completed at Uppsala University in Sweden, which found that women with ADHD who are taking hormone based birth control pills are five times more likely to experience depression than women who do not have ADHD or than women with ADHD who use other forms of birth control. It seems like everything makes the case for we need more research.

[Ashley Eng]

Yes, I think that is definitely where we're at right now, where there's just this overwhelming need for more research in this area.

[Danielle Elliott]

And even when research is done, it takes a long time to develop new treatments. The process of getting research from the lab to the people at Impacts, known as bench to bedside, takes an average of 17 years. I asked her what we can hope for. What would progress look like 15 years from now?

[Ashley Eng]

I'd be happy that if in 15 years this was something that physicians even knew about, that they were talking about with their patients, that this is something that they might be experiencing. So if we can get to that point and researchers have moved on to interventions. I think that that would be an okay place for us to be. It's kind of a slow moving process, but that is kind of the realistics of research.

[Danielle Elliott]

It's possible that this will move faster because we don't need to discover and test new medications. Rather we need to figure out how to better use the existing ones. An increase in attention on this subject might also help. Ashley told me she gets a lot of emails from young researchers who are interested in studying hormones and adhd, and that gives her hope that research will push forward so long as it gets funded. The third goal of Ashley's work is to improve the assessment process. And as we started talking about that goal, I realized her work sheds light on one of my main questions. Is it possible to develop ADHD later in life? Her study indicates that hormonal changes can create different levels of impairment in different women. This stuff is complicated, but to me at least, this suggests that some women only begin to really struggle with ADHD as they get older. The DSM currently says that symptoms must develop by the age of 12. That's an improvement from the original guideline, which called for symptoms to develop by the age of seven. Still, 12 might not be a big enough change. Ashley's study indicates that it's possible that like so much with adhd, this diagnostic criteria is based too heavily on observations of boys.

[Ashley Eng]

I think overall it is a criteria that might need some flexibility. I think 12 is a very arbitrary number and so that could be something that's updated in the future.

[Danielle Elliott]

Ashley's study was published in the journal Hormones and behavior in February 2024. Experts in the field celebrated her work. A prominent ADHD expert, Dr. Russell Barkley, praised it on his YouTube page. He posted a video explaining the importance of Ashley's study. Despite years of patient reports, he said there was almost no research up until a few years ago on this topic and the research remains very small, probably less than five studies I'm aware of on this topic. He explained that the ratio of boys to girls with ADHD is about three to one in childhood. By adulthood, it's now about one and a half men to every woman. Ashley's paper finally offered an explanation for for this shrinking gender gap as people age. The answer? It's what women have been saying all along. Hormones. And Dr. Barclay thinks Ashley's right about this. I think it's a very important hypothesis that likely will stand up over time. Dr. Barclay called for more research in the area. We'll have More soon when Dr. Martel publishes the results. Of her long term study of ADHD symptoms in young women. A researcher I spoke with in London will release the results of a study examining ADHD symptoms during menopause. A fairly new research center at Duke University will likely add more research in the future. The Duke center for Girls and Women with adhd, the first of its kind at an academic institution, is currently focusing on educational tools as well as partnerships to support women with ADHD through pregnancy and perimenopause. Eventually, the center will conduct original research, and in another first, the center is taking a unique approach.

[Dr. Julia Schechter]

Before we jump into research, we really need to understand what girls and women with ADHD actually want researchers to study.

[Danielle Elliott]

This is Dr. Julia Schechter. She's a clinical psychologist and the co director of the Duke center for Girls and Women with adhd.

[Dr. Julia Schechter]

And so what we did was we held what we call listening and learning sessions. They're focus groups, essentially, of different groupings. So we had women with adhd. We actually had a group of post menopausal women with adhd. We had teen girls with adhd. We had parents of girls, mental health providers, medical providers. We brought them together for these sessions, and then we just listened and just heard about their experiences and their challenges. We talked about their strengths, too. But really we wanted to draw from these conversations key areas of uncertainty. What are they uncertain about? And what do they want researchers to focus on?

[Danielle Elliott]

The groups came up with 46 research topics. The center turned the topics into a survey distributed to more than 1,100 women with ADHD. The survey asked respondents to rank the 46 topics in order of priority.

[Dr. Julia Schechter]

What was very clear from this project is really across groups. So girls and women with adhd, parents, educators, mental health, medical providers. What they want more of is to better understand the role of hormones on ADHD symptoms and how it impacts ADHD across the lifespan. That was just the very clear frontrunner in terms of research. So we are excited to, you know, we're listening. We're listening to those results and thinking about research projects that can address that.

[Danielle Elliott]

Those research projects will address the questions I'm seeing women post online and hearing women ask in casual conversations and interviews. That Duke is turning to women to decide what to study is a sign of progress. It's exciting, but she reminded me to temper my excitement.

[Dr. Julia Schechter]

I think this has not been an area that has been well funded, and I think that, you know, thankfully, I think it's getting a lot more attention and I think the funding will follow. But, you know, again, the funding will come. The research will come. It's still going to be, you know, almost two decades before it's going to get into the hands of the people who really need it.

[Danielle Elliott]

Two decades is a long time, and many women are not interested in waiting. Some are already experimenting on Reddit. They describe trying different types of birth control and hormone replacement therapies to treat their adhd. Some say they skip the placebo week of their monthly birth control supply to keep their symptoms under control. One said her doctor has her take an extra 10 milligrams of ADHD medication during the week leading up to her period. A woman in perimenopause reported that hormone replacement therapy is helping with her adhd. Summing up the seemingly collective desperation, one woman wrote, scariest part is it's taken me way too long to find answers for this online. Left me feeling quite hopeless. But I now have a direction I'm confident in. She'd found that direction through others on Reddit. Women are helping each other find answers, often in the absence of more scientific answers. For every woman who skirts the regulations and finds ways to experiment with hormone based medications, many others write about doctors brushing off their concerns about hormones or their request to try hormone based treatments. So far, there just isn't enough scientific evidence to support prescribing a particular birth control for women with ADHD or adjusting medications as hormones fluctuate. When I spoke with Ashley, she stressed that scientific research could conclude that the risks outweigh the benefits. She also emphasized that it will not be a one size fits all approach. We need more studies like Ashley's, perhaps even studies that consider actual adult women, rather than extrapolating from research on adolescents and teens. Whether we'll ever have this evidence based advice will depend on whether more studies are funded. I'm cautiously optimistic that more studies will be funded, thanks in large part to the rise in rates of ADHD among women. I'm also optimistic that the timeline might start to move more quickly with the help of artificial intelligence. In the uk, a team of engineering and medical researchers are developing a machine to use AI to diagnose adhd. The machine has so far detected ADHD with about an 87% rate of success. Researchers are also using AI to study the effectiveness of different treatments for ADHD or elements of treatment like exercise. Perhaps someone will soon ask AI to figure out how hormones impact ADHD symptoms and how to incorporate this into individual treatment. Perhaps there's one more trend giving me hope. A book called the XX Brain describes female specific approaches to Alzheimer's disease. It discusses scientific Evidence that women and men experience Alzheimer's differently and react differently to treatments. In the future, we will likely start to see the same in other conditions, particularly conditions that affect the brain, like dementia and perhaps adhd. Recently, I've been looking into research about pregnancy and adhd. Is it safe to take stimulants while pregnant, while breastfeeding? So far, study results are conflicting. It's confusing. There are other questions, things I haven't even thought of or seen anyone asking on Reddit. Remember Emily Mitchell from the first episode? Emily was diagnosed with hyperkinetic syndrome of childhood in the 1960s and with ADD in the late 1980s. Throughout her life, she's always thought about how to keep her brain healthy. But she started asking this question with more urgency in 2022. That year, Emily was diagnosed with breast cancer and found out that she was eligible for a fairly new type of treatment. It includes taking estrogen blockers. She was 65 and had already gone through menopause, so she knew her body wasn't producing as much estrogen as it used to. But she also knew that estrogen is instrumental in cognitive function.

[Emily Mitchell]

So if you're losing estrogen, what else have you got? You know, you give up that. So what's going to happen? Will I lose my mind? So do I give up? I was thinking of it as quality of life, as if I were giving up my brain if I take this.

[Danielle Elliott]

Emily ultimately decided to take an estrogen blocker. With her doctors, she kept a close eye on brain function. Pretty quickly, she noticed a difference.

[Emily Mitchell]

I was finding myself in meetings where I couldn't think the thing through. It was cognition. It's the, you know, the thing, the mojo you're looking for. And so it was affecting just the brain's calculus. You know, you're talking and you're in a meeting or something, and you have to. It was just affecting my ability to do that.

[Danielle Elliott]

She switched medications and felt an improvement on the second medication.

[Emily Mitchell]

And because it was better, I know that there's something to it. I'm just not sure exactly how it works. So I'm now that is my current kind of work now is to understand that better.

[Danielle Elliott]

It's great that Emily's new treatment worked, but fascinating and also frustrating that no one can explain exactly how or why Emily knew to ask these questions because she's always known how her brain works. With the recent rise in diagnosis, I have to imagine many more women will be asking this question in the course of cancer treatments. So far, there just aren't enough scientific studies recommending the best courses of treatment for Women with ADHD As I said in the first episode, Emily's experience is remarkable in that for the most part, science kept pace with her life. To have had an appropriate diagnosis and treatment as a child in the 1960s and again as a young working mom in the 1980s, this is so rare. Doctors provided answers every time she started asking questions. Will anyone rise to that challenge now? During the pandemic, the topic of ADHD suddenly seemed to be everywhere, particularly the topic of ADHD and women. And it wasn't just something I was overhearing in bars and on the subway. Major media outlets were questioning why so many women were being diagnosed. Lately, though, the media explosion seems to have subsided a little, and that worries me a little. Recently, I've read or heard a couple of stories, all told by men so far that seem to downplay ADHD as a disorder. This also worries me. You know what really worries me? In reporting this story? I spoke with a psychiatrist who told me that we're getting ADHD all wrong. He's one of the authors of a 2006 paper on the evolutionary benefits of ADHD. He told me that when we talk about ADHD, we're probably grouping many different types of brains into one category. He said that there are probably thousands of types of brains within the global population and we can't begin to comprehend the level of neurodiversity in the world. And so he doesn't think it's responsible to group many neurodivergences into a single disorder. I know it's important to question if the medical field is right about diagnoses. It's important to revise definitions when definitions are no longer serving people, but to stop acknowledging one of the most treatable forms of neurodivergence just because it might be too broad and to do so right, as we understand and accept that tons of women have this neurodivergence. That doesn't seem responsible to me either. I trust his research showing that having ADHD was beneficial in the past. But we live in the present. The modern world is different. It's hard on all brains and seems to make ADHD more challenging to manage. Having a diagnosis for ADHD opens the door to treatments. Maybe as we consider new forms of treatment, we should be looking beyond, beyond individual or personalized approaches. If women were not expected to handle the majority of executive functioning tasks at home or at work, if the world didn't rely on addictive technology, if we all moved and connected more, ADHD might be a little bit easier to manage. But the need for societal solutions doesn't replace the need for individual treatment. And it's time for that individual treatment to consider the experiences of women I started this podcast asking why so many women are being diagnosed with adhd. People told me we just didn't understand ADHD in girls and women. They were wrong. Sari Solden told me there's a simple answer. The Pandemic and TikTok. Ned Hallowell told me there's environmentally induced ADHD and that modern life is making ADHD symptoms worse. On Reddit, women are certain that decreasing estrogen during perimenopause and menopause brings on adhd. I think it's more complicated than all of this, but I also have my own simple answer. Why women? Why now? Because throughout history we did not prioritize women's health and now women are demanding that we do Climbing the Walls was written and reported by me, Danielle Elliott. It was edited by Neil Drumming, Sound design by Cody Nelson. Brianna Berry was our Production director, Ash Beecher was our supervising producer and Diana White was our Associate producer. Fact Checking by Mary Mathis, Research by Karen Watanabe. Our music was composed by Kwame Brandt Pierce with additional music provided by Blue Dot Sessions and our mixing was done by Justin D. Wright. This series was brought to you by Understood.org, a non profit organization dedicated to empowering people with learning and thinking differences like ADHD and dyslexia. From Understood.org, our executive directors are Laura Key, Scott Cochier and Seth Melnick. A very special thanks to Ray Jacobson, Julie Zeitz, Jordan Davidson, Sarah Greenberg and Kathleen Nadeau. If you want to help Understood continue this work, consider making a [e-mail] give.